2006 pharmaceutical companies how to break the deadlock price reduction-.docVIP

2006 pharmaceutical companies how to break the deadlock price reduction-.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
2006 pharmaceutical companies how to break the deadlock price reduction-

 PAGE \* MERGEFORMAT 33 2006 pharmaceutical companies how to break the deadlock price reduction? In 2006, drug price reductions in turn the 18th kicked off: drug prices continuing to fall is inevitable. Cost of drugs is the focus of all the people, but also the most direct and effective competition in the market leverage; wind and rain, such as unlucky at the same time, various factors make the cost of higher sales of drugs. Survival of the fittest, cruel face of reality, paradoxically, the main bearer of how pharmaceutical companies as a? As a ‘not even seated,’ What is the circulation and end-feel? This invited the manufacturing, distribution, terminal three people, express their views, contending the exchange, how to resolve conflicts as to ride out tough times? Presided over: Left-liang (State Food and Drug Administration Training Center brand marketing experts) Peng Chun-Yu (Sales and Marketing assistant managing editor version) Under the trend of drug price cuts -- Pharmaceutical companies: four big dilemma Chu Kuang Shan served as general manager of sales CONBA, now CONBA Chief Advisor Over the past eight years in a row 17 times lower prices resulted in an overall drug prices pharmaceutical companies greatly pulled down from the peak year to the low-bit, manufacturers as a whole into a low-profit era, caught among the four kinds of embarrassment: 1. Price dilemma Continuous drug prices pharmaceutical companies have greatly damage the normal survival and development of a direct denial of their profits, while the rigidity of the field of pharmaceutical marketing costs are not reduced because of drug prices: the special market environment, making marketing costs not by the Pharmaceutical companies say goes. 2. The cost of the plight of The past two years, the overall cost of the pharmaceutical industry has been constantly raising: raw and auxiliary materials, energy, transport and so on in price increases circulation, GMP transformation caused a

文档评论(0)

jiupshaieuk12 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档